Kara Wegermann, MD

Start Year
2017

Education and Training

College/University
Stanford University

Medical School
Harvard Medical School

Residency
Duke University

Career and Research Goals

My research interest is genetics of non-alcoholic fatty liver disease (NAFLD). I plan to pursue a career in academic hepatology.

Honors, awards and distinctions

  • Emerging Liver Scholar, American Association for the Study of Liver Diseases (2015)
  • Chief Resident for Internal Medicine, Durham VA Medical Center, 2018-19

Publications

Patel, Yuval A., Kara Wegermann, Carl L. Berg, and Lindsay Y. King. “Patient 1 with decompensated nonalcoholic steatohepatitis cirrhosis with inability to lose weight should undergo transplantation..” Clin Liver Dis (Hoboken) 11, no. 6 (June 2018): 149–51. https://doi.org/10.1002/cld.703.

PMID
30992806
Full Text

Wegermann, Kara, Anna Mae Diehl, and Cynthia A. Moylan. “Disease pathways and molecular mechanisms of nonalcoholic steatohepatitis..” Clin Liver Dis (Hoboken) 11, no. 4 (April 2018): 87–91. https://doi.org/10.1002/cld.709.

PMID
30992796
Full Text

Wegermann, Kara, Ricardo Henao, Anna Mae Diehl, Susan K. Murphy, Manal F. Abdelmalek, and Cynthia A. Moylan. “Branched chain amino acid transaminase 1 (BCAT1) is overexpressed and hypomethylated in patients with non-alcoholic fatty liver disease who experience adverse clinical events: A pilot study..” Plos One 13, no. 9 (January 2018). https://doi.org/10.1371/journal.pone.0204308.

PMID
30265706
Full Text

Seraj, Siamak M., Emily J. Campbell, Sarah K. Argyropoulos, Kara Wegermann, Raymond T. Chung, and James M. Richter. “Hospital readmissions in decompensated cirrhotics: Factors pointing toward a prevention strategy..” World Journal of Gastroenterology 23, no. 37 (October 2017): 6868–76. https://doi.org/10.3748/wjg.v23.i37.6868.

PMID
29085229
Full Text

Abril, Maria K., Adam S. Barnett, Kara Wegermann, Eric Fountain, Andrew Strand, Benjamin M. Heyman, Britton A. Blough, et al. “Diagnosis of Capnocytophaga canimorsus Sepsis by Whole-Genome Next-Generation Sequencing..” Open Forum Infect Dis 3, no. 3 (September 2016). https://doi.org/10.1093/ofid/ofw144.

PMID
27704003
Full Text

Mueller, Jessica L., Lindsay Y. King, Kara B. Johnson, Tian Gao, Lauren D. Nephew, Darshan Kothari, Mary Ann Simpson, et al. “Impact of EGF, IL28B, and PNPLA3 polymorphisms on the outcome of allograft hepatitis C: a multicenter study..” Clin Transplant 30, no. 4 (April 2016): 452–60. https://doi.org/10.1111/ctr.12710.

PMID
26854475
Full Text

King, Lindsay Y., Claudia Canasto-Chibuque, Kara B. Johnson, Shun Yip, Xintong Chen, Kensuke Kojima, Manjeet Deshmukh, et al. “A genomic and clinical prognostic index for hepatitis C-related early-stage cirrhosis that predicts clinical deterioration.” Gut 64, no. 8 (August 2015): 1296–1302. https://doi.org/10.1136/gutjnl-2014-307862.

Full Text

Johnson, Kara B., Jessica L. Mueller, Tracey G. Simon, Hui Zheng, Lindsay Y. King, Robert S. Makar, Debra A. Gervais, and Raymond T. Chung. “Reduced Albumin Dosing During Large-Volume Paracentesis Is Not Associated with Adverse Clinical Outcomes.” Digestive Diseases and Sciences 60, no. 7 (July 2015): 2190–95. https://doi.org/10.1007/s10620-015-3578-z.

Full Text

Wu, Ying, Kara B. Johnson, Giorgio Roccaro, Joanna Lopez, Hui Zheng, Anthony Muiru, Nneka Ufere, Ruma Rajbhandari, Omar Kattan, and Raymond T. Chung. “Poor Adherence to AASLD Guidelines for Chronic Hepatitis B Management and Treatment in a Large Academic Medical Center.” American Journal of Gastroenterology 109, no. 6 (June 2014): 867–75. https://doi.org/10.1038/ajg.2014.72.

Full Text

Johnson, Kara B., Emily J. Campbell, Heng Chi, Hui Zheng, Lindsay Y. King, Ying Wu, Andrew DeLemos, et al. “Advanced Disease, Diuretic Use, and Marital Status Predict Hospital Admissions in an Ambulatory Cirrhosis Cohort.” Digestive Diseases and Sciences 59, no. 1 (January 2014): 174–82. https://doi.org/10.1007/s10620-013-2832-5.

Full Text

Pages